Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Krukenberg Tumor × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 133 Breast Neoplasms 126 Neoplasms 58 Prostatic Neoplasms 54 Multiple Myeloma 52 Lung Neoplasms 44 Neoplasm Metastasis 40 Parkinson Disease 4, Autosomal Dominant Lewy Body 36 Ovarian Neoplasms 34 Colorectal Neoplasms 34 Leukemia, Lymphocytic, Chronic, B-Cell 30 Squamous Cell Carcinoma of Head and Neck 26 Recurrence 26 Leukemia, Myeloid, Acute 25 Myasthenia Gravis 24 Carcinoma, Hepatocellular 24 Stomach Neoplasms 23 Carcinoma, Renal Cell 23 Urinary Bladder Neoplasms 22 Small Cell Lung Carcinoma 21 Melanoma 20 Brain Neoplasms 20 Lymphoma, Large B-Cell, Diffuse 19 Lymphoma, Follicular 19 Endometrial Neoplasms 19 Triple Negative Breast Neoplasms 18 Pancreatic Neoplasms 16 Colonic Neoplasms 16 Head and Neck Neoplasms 15 Glioblastoma 15

Interventions

Laparotomy 1 Hyperthermic Intraperitoneal Chemotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01226394 2026-04-06

ProphyloCHIP

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed

Krukenberg Tumor, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡